1 01/04/2024 31/03/2025 2025-03-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-04-01 Sage Accounts Production 25.0 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 14570203 2024-04-01 2025-03-31 14570203 2025-03-31 14570203 2024-03-31 14570203 2023-04-01 2024-03-31 14570203 2024-03-31 14570203 2023-03-31 14570203 bus:RegisteredOffice 2024-04-01 2025-03-31 14570203 bus:Director1 2024-04-01 2025-03-31 14570203 core:WithinOneYear 2025-03-31 14570203 core:WithinOneYear 2024-03-31 14570203 core:ShareCapital 2025-03-31 14570203 core:ShareCapital 2024-03-31 14570203 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 14570203 core:Non-currentFinancialInstruments 2025-03-31 14570203 core:Non-currentFinancialInstruments 2024-03-31 14570203 bus:SmallEntities 2024-04-01 2025-03-31 14570203 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 14570203 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 14570203 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 14570203 bus:FullAccounts 2024-04-01 2025-03-31
Company registration number: 14570203
FAROOQ & CO (HOLDINGS) LTD
Unaudited filleted financial statements
31 March 2025
FAROOQ & CO (HOLDINGS) LTD
Contents
Directors and other information
Statement of financial position
Notes to the financial statements
FAROOQ & CO (HOLDINGS) LTD
Directors and other information
Director Mr Irfan Mansoor
Company number 14570203
Registered office Suite 14
45 St Mary's Road
Ealing
London
W5 5RG
FAROOQ & CO (HOLDINGS) LTD
Statement of financial position
31 March 2025
2025 2024
Note £ £ £ £
Fixed assets
Investments 4 544,710 544,710
_______ _______
544,710 544,710
Creditors: amounts falling due
within one year 5 ( 544,610) ( 544,610)
_______ _______
Net current liabilities ( 544,610) ( 544,610)
_______ _______
Total assets less current liabilities 100 100
_______ _______
Net assets 100 100
_______ _______
Capital and reserves
Called up share capital 100 100
_______ _______
Shareholder funds 100 100
_______ _______
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 29 December 2025 , and are signed on behalf of the board by:
Mr Irfan Mansoor
Director
Company registration number: 14570203
FAROOQ & CO (HOLDINGS) LTD
Notes to the financial statements
Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is Suite 14, 45 St Mary's Road, Ealing, London, W5 5RG.
2. Accounting policies
Accounting convention
These financial statements have been prepared in accordance with FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" ('FRS 102') and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a fair view. The financial statements are prepared in Sterling which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £. The financial statements have been prepared under historical cost convention. The principal accounting policies adopted are set out below.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
3. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
4. Investments
Shares in group undertakings and participating interests Total
£ £
Cost
At 1 April 2024 and 31 March 2025 544,710 544,710
_______ _______
Impairment
At 1 April 2024 and 31 March 2025 - -
_______ _______
Carrying amount
At 31 March 2025 544,710 544,710
_______ _______
At 31 March 2024 544,710 544,710
_______ _______
5. Creditors: amounts falling due within one year
2025 2024
£ £
Amounts owed to group undertakings and undertakings in which the company has a participating interest 394,610 322,610
Other creditors 150,000 222,000
_______ _______
544,610 544,610
_______ _______
6. Related party
At the financial year end date, included in other creditors is amount due to a related party, Farooq & Co (London) Ltd, a company registered in England & Wales. The amount due to this company at the financial year end date was £394,610 (FY2024: £322,610).